Dr Mrunal Jaywant (USP India)

Reflecting on five years of quality control for nitrosamine impurities

Since the US Food and Drug Administration (FDA)’s report on…

29 June 2023 | By Dr Mrunal Jaywant (USP India)

Since the US Food and Drug Administration (FDA)’s report on a series of nitrosamine-related impurity drug recalls in 2018, pharma has made great strides in its ability to detect and control for these impurities. Dr Mrunal Jaywant, Vice President of R&D at USP India proposed a collaborative, cross-community approach between…